TW432047B - Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists - Google Patents

Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists Download PDF

Info

Publication number
TW432047B
TW432047B TW086111948A TW86111948A TW432047B TW 432047 B TW432047 B TW 432047B TW 086111948 A TW086111948 A TW 086111948A TW 86111948 A TW86111948 A TW 86111948A TW 432047 B TW432047 B TW 432047B
Authority
TW
Taiwan
Prior art keywords
optical waveguide
slot
optical
base layer
optionally substituted
Prior art date
Application number
TW086111948A
Other languages
English (en)
Inventor
Fumitaka Ito
Hiroshi Kondo
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of TW432047B publication Critical patent/TW432047B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

101年.03月0'2日修正誉換百 M432047 五、新型說明： 【新型所屬之技術領域】 [0001] 本創作係有關一種光波導組件，尤其涉及一種光波導組 件的定位結構。 【先前技術】 [0002] 於2010年11月02日公告的美國專利第US7, 542, 643B2號 揭示了一種具有固定結構的光波導組件。所述光波導組 件可向前***插座配合，其包括若干光波導及固定光波 導的套管，所述各光波導包括基板、基層、彼此相隔一 定距離排列於基層上的波導核心及包覆於基層與波導核 心的外包層，所述套管設有一個開槽，所述開槽前後方 向貫通，所述光波導堆疊裝置於所述開槽内。然而，此 種製造方法由於係將一層層光波導依序堆疊在套管的一 個開槽内，隨著一層層的公差累積，越上層的光波導， 其沿所述開槽開口方向的正位度影響越大。 [0003] 是以，針對上述問題，有必要對前述套管進行改造。 【新型内容】 [0004] 本創作之目的在於提供一種光波導組件，其對光波導具 有1¾定位精度。 [0005] 為解決前述技術問題，本創作光波導組件可向前***插 座配合，其包括若干光波導及固定光波導的套管，所述 各光波導包括基板、基層、彼此相隔一定距離排列於基 層上的波導核心及包覆於基層與波導核心的外包層，所 述套管設有多個開槽，各開槽前後方向貫通，所述光波 10022267产單編號 A〇101 第3頁/共12頁 1013077521-0 M432047 101年.03月日梭正替换頁 導分成多組並分別堆疊裝置於各開槽内。 [0006] 與先前技術相比，本創作光波導組件具有如下功效: [0007] 所述套管設有多個開槽，各開槽前後方向貫通，所述光 波導分成多組並分別堆疊裝置於各開槽内。這樣設計使 光波導組件在維持相同光波導層數的條件下，減少光波 導的堆疊數量，從而使累積公差縮小，提高定位精度。 [0008] 本新型的其他具體設計如下： [0009] . 其中前述多個開槽包括一個向上側開口的上開槽與一個 向下側開口的下開槽，所述光波導分別豎直方向堆疊設 置於前述上開槽與下開槽。 [0010] 其中前述上開槽與下開槽沿豎直方向對齊。 [0011] 其中前述上下開槽沿水平方向的寬度需較光波導寬度更 寬2〜4微米。 [0012] 其中前述光波導組件還包括設置於上開槽内的光波導上 側的頂蓋與設置於下開槽内的光波導下側的底蓋，用於 壓合光波導。 [0013] 其中前述套管具有設置於上開槽與下開槽之間的分隔壁 、及處於分隔壁水平兩端的定位孔，所述定位孔可與插 座導向配合。 [0014] 其中前述頂蓋與光波導之間、底蓋與光波導之間均具有 預留給固定膠的空間，頂蓋與底蓋是利用固定膠與光波 導黏合。 【實施方式】26#單编號A〇101 第4頁/共12頁 1013077521-0 M432047 1101 年03月 〇·2 [0015] 下面結合附圖來詳細說明本創作之具體實施方式。 [0016] 請參閲第一圖及第四圖所示，本創作係一種光波導組件 100，其可向前***插座配合，所述光波導組件10()包括 若干光波導140、固定光波導140的套管110以及用於壓 合光波導140的頂蓋120與底蓋13〇，所述各光波導140包 括基板141、基層143、波導核心142及外包層144，所述 波導核心142彼此相隔一定距離排列於基層143上，所述 外包層144熔於基層143從而包覆於波導核心142 ^所述 套官110設有兩個開槽、設置於兩個開槽之間的分隔壁 111及處於分隔壁111水平兩端的定位孔112，所述定位 孔112可與插座導向配合。所述套管11〇包括一個向上侧 開口的上開槽14 6與一個向下側開口的下開槽14 7，所述 上開槽14 6與下開槽14 7沿豎直方向對齊，各開槽前後方 向貫通，所述上下開槽沿水平方向的寬度需較光波導14〇 寬度更寬2>·4微米。所述光波導14〇分別豎直方向堆疊設 置於前述上開槽146與下開槽147。所述頂蓋120設置於 上開槽146内光波導140的上側，所述底蓋13〇設置於下 開槽147内光波導140的下側’所述頂蓋12〇與底蓋130用 於壓合光波導14(^所述頂蓋120與光波導14〇之間、底 蓋130與光波導140之間均具有預留給固定膠丨45的空間， 頂蓋120與底蓋130是利用固定膠145與光波導140黏合。 [00Π] 综上所述，本創作確已符合新型專利之要件，爰依法提 出專利申請》惟，以上所述者僅係本創作之較佳實施方 式，本創作之範圍並不以上述實施方式爲限，舉凡熟習 本案技藝之人士援依本創作之精神所作之等效修飾或變 10022267产單編號 A0101 第5頁/共12頁 1013077521-0 M432047 101年03月0>日核正替換頁 化，皆應涵以下申請專利範圍内。 【圖式簡單說明】 [0018] 第一圖係符合本發明的一種光波導組件的立體圖。 [0019] 第二圖係第一圖中光波導組件的立體***圖。 [0020] 第三圖係第一圖中光波導組件的前視圖。 [0021] 第四圖係第二圖中套管的立體圖。 【主要元件符號說明】 [0022] 光波導組件100 · [0023] 套管 1 1 0 [0024] 分隔壁111 [0025] 定位孔112 [0026] 頂蓋 120 [0027] 底蓋 130 [0028] 光波導 140 # [0029] 基板 141 [0030] 波導核心142 - [0031] 基層 143 [0032] 外包層144 [0033] 固定膠145 [0034] 上開槽146 10〇222^科號删1 第6頁/共12頁 1013077521-0 M432047 [0035] 下開槽147 101年.03月的日梭正替&頁
1〇〇2226#料號删1 第7頁/共12頁 1013077521-0 Μ432^,^^ . 200222678 _____ ※記號部分請勿填寫 ※申請案號：100222678 ※申請日：/"6^. Q 一、新型名稱： 寬專收字第：1013〇77521- .1〇1年.03月0>日按正_頁 丨__ 舰日 ^IPC^： (2006.01) Ο 光波導組件
OPTICAL WAVEGUIDE ASSEMBLY 二、中文新型摘要： 本創作係提供一種光波導組件，可向前***插座配合，其包 括若干光波導及固定光波導的套管，所述各光波導包括基板 、基層、彼此相隔一定距離排列於基層上的波導核心及包覆 於基層與波導核心的外包層，所述套管設有多個開槽，各開 槽前後方向貫通，所述光波導分成多組並分別堆疊裝置於各 開槽内。 三、英文新型摘要：
An optical waveguide assembly used for mating forwardly into a socket, includes a number of optical waveguides and a ferrule which receiving the optical waveguides, Each of the optical waveguides includes a substrate, a base layer, a number of waveguide cores arraying on the base layer and a clad layer covering the base layer and the waveguide cores. The ferrule defines a number of slots, extending there through forwardly .The optical waveguides are divided into a number of groups and each group of the optical waveguides is stacked in corresponding slot. 10022267#單編號 A0101 第1頁/共12頁 1013077521-0 M432047 _ 101年.03月0乏日按正替換頁 六、申請專利範圍： 1 · 一種光波導組件，可向前***插座配合，其包括若干光波 導及固定光波導的套管，所述各光波導包括基層、壓合於 基層上的基板、彼此相隔一定距離排列於基層上的波導核 心及包覆於基層與波導核心的外包層，其特徵在於：所述 •套管設有多個開槽，各開槽前後方向貫通，所述光波導分 成多組並分別堆疊裝置於各開槽内。 2.如申請專利範圍第丨項所述之光波導組件，其中前述多個 開槽包括一個向上側開口的上開槽與一個向下側開口的下 開槽，所述光波導分別豎直方向堆疊設置於前述上開槽與 · 下開槽。 3 .如申請專利範圍第2項所述之光波導組件，其中前述上開 槽與下開槽沿豎直方向對齊。 4 .如申請專利範圍第2項所述之光波導組件，其中前述上下 開槽沿水平方向的寬度需較光波導寬度更寬微米。 5 .如申請專利範圍第2項所述之光波導組件，其中前述光波 導組件還包括設置於上開槽内的光波導上側的頂蓋與設置 於下開槽内的光波導下側的底蓋，用於壓合光波導。 ^ 6 ·如申請專利範圍第2項所述之光波導組件，其中前述套管 具有δ又置於上開槽與下開槽之間的分隔壁、及處於分隔壁 水平兩端的定位孔，所述定位孔可與插座導向配合。 7 ·如申請專利範圍第5項所述之光波導組件，其中前述頂蓋 與光波導之間、底蓋與光波導之間均具有預留給固定膠的 空間，頂蓋與底蓋是利用固定膠與光波導黏合。 1〇〇22267卢單編號 Α0101 第8頁/共12頁 1013077521-0
Viol 棱正 m^〇A1 七、®式·
1〇13〇^521 第9 $ 兵 12育 M432047 101年.03月02日修正替換頁
1013077521-0 M432047
10022267产概 Α〇101 101年.03月02日修正替換頁
第二圖 第11頁/共12頁 1013077521-0 M432047 101年.03月0乏日核正替換頁 ⑽22267#單编號
第四圖 第12頁/共12頁
1013077521-0 M432047 101年03月02日修正替換頁 四、指定代表圖： (一) 本案指定代表圖為：第（三）圖 (二) 本代表圖之元件符號簡單說明： 套管：110 分隔壁：111 定位孔：112 基板：141 基層：143 外包層：14 4 波導核心：142 ^ 固定膠：145 10022267#單编號 A〇101 第2頁/共12頁 1013077521-0
TW086111948A 1996-09-18 1997-08-20 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists TW432047B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IBPCT/IB96/00957 1996-09-18

Publications (1)

Publication Number Publication Date
TW432047B true TW432047B (en) 2001-05-01

Family

ID=11004480

Family Applications (1)

Application Number Title Priority Date Filing Date
TW086111948A TW432047B (en) 1996-09-18 1997-08-20 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists

Country Status (38)

Country Link
US (7) US6201007B1 (zh)
EP (1) EP0934264B1 (zh)
JP (2) JP3195368B2 (zh)
KR (1) KR100339666B1 (zh)
CN (1) CN1237962A (zh)
AP (1) AP1016A (zh)
AR (1) AR008168A1 (zh)
AT (1) ATE249433T1 (zh)
AU (1) AU719895B2 (zh)
BG (1) BG64194B1 (zh)
BR (1) BR9711506A (zh)
CA (1) CA2266006C (zh)
CO (1) CO4920224A1 (zh)
DE (1) DE69724805T2 (zh)
DK (1) DK0934264T3 (zh)
DZ (1) DZ2309A1 (zh)
EA (1) EA001341B1 (zh)
ES (1) ES2205248T3 (zh)
HR (1) HRP970509A2 (zh)
ID (1) ID19611A (zh)
IL (3) IL147368A0 (zh)
IS (1) IS4992A (zh)
MA (1) MA26441A1 (zh)
NO (1) NO313550B1 (zh)
NZ (1) NZ334439A (zh)
OA (1) OA10996A (zh)
PA (1) PA8437201A1 (zh)
PE (1) PE109998A1 (zh)
PL (1) PL332546A1 (zh)
PT (1) PT934264E (zh)
SK (1) SK32799A3 (zh)
TN (2) TNSN97092A1 (zh)
TR (1) TR199900590T2 (zh)
TW (1) TW432047B (zh)
UA (1) UA60310C2 (zh)
WO (1) WO1998012177A1 (zh)
YU (1) YU13899A (zh)
ZA (1) ZA978358B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051587A1 (fr) 1998-04-01 1999-10-14 Ono Pharmaceutical Co., Ltd. Derives de thiophene condenses et medicaments contenant ceux-ci comme principe actif
EP0982297A3 (en) * 1998-08-24 2001-08-01 Pfizer Products Inc. Process for the preparation of hydroxy-pyrrolidinyl hydroxamic acid derivatives being opioid kappa receptor agonists
AU2002247886A1 (en) * 2001-04-30 2002-11-11 Pfizer Products Inc. Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists
WO2003072544A1 (en) * 2002-02-28 2003-09-04 Pfizer Products Inc. Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n-{2{n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine
AU2003269399A1 (en) * 2002-11-01 2004-05-25 Pfizer Products Inc. Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination
CN1972914A (zh) * 2004-03-31 2007-05-30 詹森药业有限公司 作为组胺h3受体配合体的非咪唑杂环化合物
US7746514B2 (en) * 2004-04-14 2010-06-29 Hung-Yi Hsu Scanner and exposure control method thereof
US20070213319A1 (en) * 2006-01-11 2007-09-13 Angion Biomedica Corporation Modulators of hepatocyte growth factor/c-Met activity
CA2653940C (en) 2006-05-30 2015-07-14 Janssen Pharmaceutica N.V. Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
CN101511807A (zh) * 2006-06-29 2009-08-19 詹森药业有限公司 组胺h3受体的取代的苯甲酰胺调节剂
CN105712977B (zh) 2007-11-20 2021-06-29 詹森药业有限公司 作为组胺h3受体调节剂的环烷基氧基吡啶化合物和杂环烷基氧基吡啶化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8801304D0 (en) 1988-01-21 1988-02-17 Ici Plc Diamine compounds
DE4034785A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
DE3935371A1 (de) 1988-12-23 1990-07-05 Merck Patent Gmbh Stickstoffhaltige ringverbindungen
US5232978A (en) * 1988-12-23 1993-08-03 Merck Patent Gesellschaft Mit Beschrankter Haftung 1-(2-arylethyl)-pyrrolidines
WO1994018165A1 (en) 1993-02-12 1994-08-18 Pfizer Inc. Sulfonamide compounds as opioid k-receptor agonists
IL117440A0 (en) * 1995-03-31 1996-07-23 Pfizer Pyrrolidinyl hydroxamic acid compounds and their production process

Also Published As

Publication number Publication date
AU3781297A (en) 1998-04-14
PT934264E (pt) 2004-01-30
PE109998A1 (es) 1999-01-13
DK0934264T3 (da) 2004-01-26
JP2001316344A (ja) 2001-11-13
EA001341B1 (ru) 2001-02-26
IS4992A (is) 1999-03-05
AP9701082A0 (en) 1997-10-31
EP0934264B1 (en) 2003-09-10
ZA978358B (en) 1999-03-17
US20010009921A1 (en) 2001-07-26
IL147367A0 (en) 2002-08-14
HRP970509A2 (en) 1998-08-31
AR008168A1 (es) 1999-12-09
DE69724805D1 (de) 2003-10-16
AU719895B2 (en) 2000-05-18
US20010011091A1 (en) 2001-08-02
ES2205248T3 (es) 2004-05-01
CO4920224A1 (es) 2000-05-29
US20010014683A1 (en) 2001-08-16
OA10996A (en) 2001-11-06
JP3195368B2 (ja) 2001-08-06
DZ2309A1 (fr) 2002-12-28
NO313550B1 (no) 2002-10-21
EP0934264A1 (en) 1999-08-11
PL332546A1 (en) 1999-09-13
NO991294D0 (no) 1999-03-17
UA60310C2 (uk) 2003-10-15
DE69724805T2 (de) 2004-07-01
US6303602B1 (en) 2001-10-16
EA199900209A1 (ru) 1999-10-28
US6313302B2 (en) 2001-11-06
US6201007B1 (en) 2001-03-13
WO1998012177A1 (en) 1998-03-26
US6307061B2 (en) 2001-10-23
ATE249433T1 (de) 2003-09-15
BG103239A (en) 1999-09-30
CA2266006C (en) 2003-11-04
US20010020024A1 (en) 2001-09-06
US6294569B2 (en) 2001-09-25
CA2266006A1 (en) 1998-03-26
MA26441A1 (fr) 2004-12-20
SK32799A3 (en) 2000-09-12
BR9711506A (pt) 1999-08-24
TR199900590T2 (xx) 1999-07-21
TNSN97156A1 (fr) 2005-03-15
IL147368A0 (en) 2002-08-14
AP1016A (en) 2001-10-08
ID19611A (id) 1998-07-23
BG64194B1 (bg) 2004-04-30
JP2000516634A (ja) 2000-12-12
US20010008890A1 (en) 2001-07-19
PA8437201A1 (es) 1999-12-27
CN1237962A (zh) 1999-12-08
YU13899A (sh) 2000-03-21
TNSN97092A1 (ar) 1999-12-31
US6310061B2 (en) 2001-10-30
KR20000036225A (ko) 2000-06-26
NZ334439A (en) 2000-09-29
US6294557B1 (en) 2001-09-25
KR100339666B1 (ko) 2002-06-05
IL128959A0 (en) 2000-02-17
NO991294L (no) 1999-03-17

Similar Documents

Publication Publication Date Title
TW432047B (en) Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
US5093879A (en) Electro-optical connectors
US20030031437A1 (en) In-line shuffle modules utilizing three dimensional optical circuits
CN106483608A (zh) 光模块
JP2005195651A (ja) 光接続基板、光伝送システム、及び製造方法
EP1415186A2 (en) In-line shuffle modules utilizing three dimensional optical circuits
CN102287681A (zh) 背光单元和显示装置
TW201245791A (en) Optical sensor module
Immonen et al. Development of electro-optical PCBs with embedded waveguides for data center and high performance computing applications
JPH11183747A (ja) 三次元高分子光導波路アレイおよびその製造方法
CN206074886U (zh) 镜头驱动装置
CN103777280B (zh) 一种具有倾斜角度的光纤装配体及其装配方法
McPhee Bernini's books
US20040108046A1 (en) Optical converter formed from flexible strips
TWM432047U (en) Optical waveguide assembly
CN106022721A (zh) 编辑***
TW200500667A (en) Optical wave-guide chip and optical component comprising same
CN211955942U (zh) 一种光纤配线箱
TW536641B (en) Fiber array base and its method of fixing fibers
CN217693930U (zh) 一种应用于软硬结合板钢片贴合的治具
CN211856974U (zh) 多芯光纤阵列
DE69936260D1 (de) Faseroptisches kabel
CN218070450U (zh) 一种垂直集成网络接口
CN215264134U (zh) 一种耦合自定位双排光纤阵列
CN217739591U (zh) 一种适用于棒透镜胶合的定位工装

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent